Skip to main content

Table 2 Studies That Assessed Outcome of PSMA PET/CT-based SRT

From: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

Author Year n Response rate Median follow-up (months)
Henkenberens 2017 23 79% 12.4
Zschaeck 2017 20 60% 29
Emmett 2017 99 72% 10.5
Schmidt-Hegemann 2018 129 83% 20
Schmidt-Hegemann 2018 90 78% 23